Granisetron
Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vo ... Read More
Entereg (alvimopan) is the first and only FDA-approved agent indicated to accelerate the time to gastrointestinal (GI) recovery following surgeries that include partial bowel resection with primary anastomosis.
Market Analysis and Insights: Global Entereg (alvimopan) Market
The global Entereg (alvimopan) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Entereg (alvimopan) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Entereg (alvimopan) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Entereg (alvimopan) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Entereg (alvimopan) market.
Global Entereg (alvimopan) Scope and Market Size
Entereg (alvimopan) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Entereg (alvimopan) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
12 mg Capsule
Type II
Segment by Application
Partial bowel resection
Radical cystectomy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vo ... Read More
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoieti ... Read More
Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates p ... Read More
Azelastine is a potent, second-generation, selective, histamine antagonist (histamine-H1-recep ... Read More